4D Transperineal Ultrasound to Check UVJ Mobility After Vaginal Laser for Stress Incontinence
Official title: Standardized 4D Transperineal Ultrasound Assessment of Urethrovesical Junction Mobility After Vaginal Laser Treatment for Stress Urinary Incontinence: a Prospective Observational Cohort Study
Run by Charles University, Czech Republic · NCT07907016 · Data updated 2026-11-12
This study tests whether three sessions of self-paid vaginal Er:YAG laser treatment change urethrovesical junction mobility in women with stress urinary incontinence.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Charles University, Czech Republic Academic / other |
| Locations | 1 site (Prague) |
| Status | Recruiting |
| Started | January 1, 2027 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT07907016 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 or older with pure stress urinary incontinence or stress-predominant mixed urinary incontinence, confirmed by urodynamics, who have independently chosen self-paid vaginal laser treatment as part of routine care.
✕Probably not a fit
Patients with predominantly overactive bladder symptoms or those who have had prior SUI surgery may not experience benefit from this assessment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center observational study enrolling 40 adult women with pure stress urinary incontinence or stress-predominant mixed incontinence. Participants receive self-paid vaginal Er:YAG laser treatment in routine care, with three sessions at 4-6 week intervals, and undergo standardized 4D transperineal ultrasound and clinical assessments at baseline and 1, 3, and 6 months after the final session. The primary outcome is the change in craniocaudal UVJ mobility from baseline to 1 month after the final treatment; secondary outcomes include UVJ mobility at later time points, UVJ position, mid-urethral morphology, patient-reported outcomes, cough stress test results, adverse events, and need for additional SUI treatment. Exploratory analyses will be performed to explore associations between imaging changes and clinical outcomes.
Why it matters
Potential benefit: If successful, the study could clarify whether vaginal laser treatment affects UVJ mobility and bladder-neck dynamics in SUI patients.
How similar studies have gone: There is limited prior evidence directly linking vaginal laser treatment to UVJ mobility changes; this study builds on observational imaging approaches in SUI care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female sex. * Age 18 years or older. * Pure stress urinary incontinence or stress-predominant mixed urinary incontinence. In women with mixed urinary incontinence, the stress component must be the dominant and most bothersome symptom. * Urodynamically demonstrated stress urinary incontinence. * Absence of detrusor overactivity on urodynamic testing. * Independent decision to undergo self-paid vaginal laser treatment as routine clinical care, made before the offer of study participation. * Ability to complete the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF). * Ability to perform a technically acceptable Valsalva maneuver. * Willingness to attend the scheduled follow-up visits. * Written informed consent to study participation. Exclusion Criteria: * Predominant overactive bladder or predominant urgency urinary incontinence. * Previous surgery for stress urinary incontinence. * Previous vaginal laser treatment. * Previous pelvic organ prolapse surgery. * Pelvic Organ Prolapse Quantification (POP-Q) stage II or greater in any compartment. * Current pessary use at enrollment. * Active pelvic floor physiotherapy at enrollment. * Previous pelvic radiotherapy. * Pregnancy. * Unexplained genital bleeding. * Pelvic malignancy. * Any other contraindication to vaginal laser treatment. * Active urinary tract or vaginal infection. Enrollment and laser treatment will be deferred until the infection has resolved.
Where it's running
-
General University Hospital in Prague
Prague, Czechia Recruiting
Study contacts
- Study coordinator: Jan Dvorak, M.D. Ph.D.
- Email: jan.dvorak2@vfn.cz
- Phone: 00420224967577
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Educational video before urodynamic testing to see if it lowers anxiety
This study tests whether watching a short educational video before urodynamics helps reduce anxiety for women undergoing the test.
-
Reliability of pelvic floor measurements from ultrasound during rest and during weightlifting
This study tests how consistently pelvic floor measurements from ultrasound can be obtained by different people and by the same person across rest and during weightlifting in adults with female anatomy.
-
Mobile app-guided pelvic floor rehab vs. in-person rehab for urinary leakage in adult women
A randomized study tests whether a mobile app-guided program can help adult women with urinary leakage as well as traditional in-person pelvic floor rehabilitation.
-
Trampoline effects on pelvic support and urine leakage
This study will try a 10-minute high-intensity trampoline session to see if it causes urine leakage or short-term changes in pelvic floor structure in active women aged 18–40 who do not usually leak.
-
Adding phenol to laser treatment for pilonidal sinus healing
This will see if adding crystallized phenol to a day-surgery laser treatment helps adults with primary pilonidal sinus heal faster and return to normal activities sooner.
-
Assessing tissue elasticity in women with urinary incontinence
This study is testing a new way to see if the stiffness of tissue around the urethra can help doctors better diagnose stress urinary incontinence in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.